Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $588.9M | $562.2M | $534.9M | $620.7M | $490.1M | $337.5M | $242.1M |
| Gross profit | $456.8M | $437.4M | $407.5M | $403.4M | $327.9M | $222.5M | $169.0M |
| Gross margin | 77.57% | 77.80% | 76.18% | 64.98% | 66.90% | 65.92% | 69.81% |
| Research & development | $79.0M | $76.2M | $72.1M | $71.6M | $49.5M | $30.4M | $26.1M |
| Operating expenses | $529.7M | $536.0M | $537.8M | $651.3M | $517.3M | $359.6M | $296.4M |
| Operating income | $59.3M | $26.2M | −$2.9M | −$30.6M | −$27.2M | −$22.0M | −$54.3M |
| Operating margin | 10.06% | 4.66% | −0.55% | −4.93% | −5.55% | −6.53% | −22.41% |
| EBITDA | $127.7M | $115.0M | $101.3M | $80.2M | $74.2M | $54.8M | −$1.3M |
| EBITDA margin | 21.68% | 20.46% | 18.94% | 12.92% | 15.15% | 16.24% | −0.54% |
| Net income | $17.6M | −$41.1M | −$45.6M | −$59.8M | −$82.0M | −$60.0M | −$93.7M |
| Net profit margin | 2.99% | −7.31% | −8.53% | −9.64% | −16.72% | −17.76% | −38.71% |
| Basic EPSper basic share | $0.10 | -$0.22 | -$0.24 | -$0.31 | -$0.82 | -$3.06 | -$14.13 |
| Diluted EPSper diluted share | $0.10 | -$0.22 | -$0.24 | -$0.31 | -$0.82 | -$3.06 | -$14.13 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026Form 4 · 10b5-1 | Remer Eric RichardChief Executive Officer | SellCommon Stock | 1.1K | $9.03 | $9.9K | 5.75M |
| Jun 16, 2026Form 4 · 10b5-1 | Remer Eric RichardChief Executive Officer | SellCommon Stock | 4.6K | $9.05 | $42.0K | 5.75M |
| Jun 10, 2026Form 4 · 10b5-1 | Remer Eric RichardChief Executive Officer | SellCommon Stock | 7.5K | $9.15 | $68.8K | 2.74M |
| Jun 9, 2026Form 4 · 10b5-1 | Remer Eric RichardChief Executive Officer | SellCommon Stock | 11.7K | $9.08 | $106.1K | 2.75M |
| Jun 3, 2026Form 4 · 10b5-1 | Remer Eric RichardChief Executive Officer | SellCommon Stock | 5.7K | $9.57 | $54.1K | 2.80M |
EverCommerce ($EVCM) increased its share-repurchase authorization by $25 million and extended the program through the end of 2027. The amendment takes the cumulative authorization from $300 million to $325 million, giving the company additi ...